A carregar...
NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis
INTRODUCTION: The absence of a reliable, universal biomarker is a significant limitation in neuroendocrine neoplasia (NEN) management. We prospectively evaluated two CgA assays, (NEOLISA, EuroDiagnostica) and (CgA ELISA, Demeditec Diagnostics (DD)) and compared the results to the NETest. METHODS: NE...
Na minha lista:
| Publicado no: | Endocr Connect |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bioscientifica Ltd
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7923057/ https://ncbi.nlm.nih.gov/pubmed/33289691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-20-0417 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|